Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mylene Huebecker

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Human Molecular Genetics|June 8, 2018
AAV9 intracerebroventricular gene therapy improves lifespan, locomotor function and pathology in a mouse model of Niemann-Pick type C1 diseaseMichael P Hughes, Dave A Smith, Lauren Morris, et al.
Acta Neuropathologica Communications|August 9, 2020
Upregulating β-hexosaminidase activity in rodents prevents α-synuclein lipid associations and protects dopaminergic neurons from α-synuclein-mediated neurotoxicityOeystein R Brekk, Joanna A Korecka, Cecile C Crapart, et al.
Human Molecular Genetics|October 21, 2015
Amyotrophic lateral sclerosis and denervation alter sphingolipids and up-regulate glucosylceramide synthaseAlexandre Henriques, Vincent Croixmarie, David A Priestman, et al.
Disease Models & Mechanisms|January 31, 2020
Genetic background modifies phenotypic severity and longevity in a mouse model of Niemann-Pick disease type C1Jorge L Rodriguez-Gil, Dawn E Watkins-Chow, Laura L Baxter, et al.
Molecular Genetics and Metabolism|January 29, 2023
Glb1 knockout mouse model shares natural history with type II GM1 gangliosidosis patientsElena-Raluca Nicoli, Mylene Huebecker, Sangwoo T Han, et al.
Nature Medicine|July 18, 2018
Fetal gene therapy for neurodegenerative disease of infantsGiulia Massaro, Citra N Z Mattar, Andrew M S Wong, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Human Molecular Genetics|June 8, 2018
AAV9 intracerebroventricular gene therapy improves lifespan, locomotor function and pathology in a mouse model of Niemann-Pick type C1 diseaseMichael P Hughes, Dave A Smith, Lauren Morris, et al.
Acta Neuropathologica Communications|August 9, 2020
Upregulating β-hexosaminidase activity in rodents prevents α-synuclein lipid associations and protects dopaminergic neurons from α-synuclein-mediated neurotoxicityOeystein R Brekk, Joanna A Korecka, Cecile C Crapart, et al.
Human Molecular Genetics|October 21, 2015
Amyotrophic lateral sclerosis and denervation alter sphingolipids and up-regulate glucosylceramide synthaseAlexandre Henriques, Vincent Croixmarie, David A Priestman, et al.
Disease Models & Mechanisms|January 31, 2020
Genetic background modifies phenotypic severity and longevity in a mouse model of Niemann-Pick disease type C1Jorge L Rodriguez-Gil, Dawn E Watkins-Chow, Laura L Baxter, et al.
Molecular Genetics and Metabolism|January 29, 2023
Glb1 knockout mouse model shares natural history with type II GM1 gangliosidosis patientsElena-Raluca Nicoli, Mylene Huebecker, Sangwoo T Han, et al.
Nature Medicine|July 18, 2018
Fetal gene therapy for neurodegenerative disease of infantsGiulia Massaro, Citra N Z Mattar, Andrew M S Wong, et al.
Pageof 2